A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

✍ Scribed by Pallis, Athanasios G.; Agelidou, Athina; Agelaki, Sofia; Varthalitis, Ioannis; Pavlakou, Georgia; Gerogianni, Aleka; Papakotoulas, Pavlos; Rapti, Ageliki; Chandrinos, Vassilis; Christophyllakis, Charalampos; Georgoulias, Vassilis

• Book ID: 119320065
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 174 KB
• Volume: 65
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2008.11.002